Additionally, MALAT1 suppresses glioma progression via reduction of extracellular signal‐regulated kinase/mitogen‐activated protein kinase signaling activity and expression of matrix metalloproteinase 2 33. This evidence concerns the gene MMP2 and central nervous system cancer.